TruSight Oncology portfolio enables clinical research and in-vitro diagnostic CGP solutions ...

An oral presentation will highlight the results of the company’s Phase 2 RAINBOW study. Additionally, five poster ...

Sagimet Biosciences (SGMT) announced the presentation of Phase 2b data demonstrating the anti-fibrotic activity of its fatty acid synthase ...

A Nigerian student is glad that he has been presented with an award of N1.2 million after he made a poster presentation on a ...

More than 40 stars of music, stage, sport and screen have joined Teenage Cancer Trust for its fundraiser, which went live on ...

Ruvindu Perera, cell and molecular biology graduate student, placed first in the Foodborne Pathogens and Contaminants in Animal-Based Products category. Amanda Anthney, poultry science graduate ...

The preclinical data presented at ACR Convergence underscore the exceptional potential of our targeted protein degradation strategy compared to kinase inhibition for both BTK and IRAK4, which are ...

On track to report topline data from Phase 2 TRANQUILITY trial in first half of 2025 – – Assembled Cardiovascular Scientific Advisory Board (CV SAB), comprised of leading academic and industry experts ...

HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial Overall, in Cohort A1, 25% of patients achieved functional ...

50% of patients (3/6) with baseline HBsAg <1000 IU/mL achieved a functional cure (defined as sustained HBsAg loss and HBV DNA ...

Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

The Warren Alpert Medical School held its 18th annual Academic Symposium Wednesday afternoon. The symposium was the largest ...